NO20074762L - Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter - Google Patents

Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter

Info

Publication number
NO20074762L
NO20074762L NO20074762A NO20074762A NO20074762L NO 20074762 L NO20074762 L NO 20074762L NO 20074762 A NO20074762 A NO 20074762A NO 20074762 A NO20074762 A NO 20074762A NO 20074762 L NO20074762 L NO 20074762L
Authority
NO
Norway
Prior art keywords
endometriosis
identification
value
blood lymphocytes
diagnostic markers
Prior art date
Application number
NO20074762A
Other languages
English (en)
Inventor
Idhaliz Flores
Spyro Mousses
Ester Rozenblum
Original Assignee
Ponce School Of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ponce School Of Medicine filed Critical Ponce School Of Medicine
Publication of NO20074762L publication Critical patent/NO20074762L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen omfatter en fremgangmåte for å identifisere eller predikere predisposisjonen til endometriose i et kvinnelig emne karakterisert ved å bestemme nivået av genuttrykk av minst et differensielt uttrykt gen eller protein eller peptid av perifere blodleukocytter i en prøve av perifere blodleukocytter eller perifert blod i et emne for å gi en første verdi, og bestemme nivået av genuttrykket av minst et differensielt uttrykt gen eller protein eller peptid av leukocyttene i en kontroll eller referansestandard for å gi en andre verdi, og å sammenligne hvorvidt det er en forskjell mellom den første verdien og andre verdien.
NO20074762A 2005-02-18 2007-09-18 Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter NO20074762L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65433105P 2005-02-18 2005-02-18
PCT/US2005/044723 WO2006091254A1 (en) 2005-02-18 2005-12-09 Identification of molecular diagnostic markers for endometriosis in blood lymphocytes

Publications (1)

Publication Number Publication Date
NO20074762L true NO20074762L (no) 2007-11-16

Family

ID=36182367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074762A NO20074762L (no) 2005-02-18 2007-09-18 Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter

Country Status (13)

Country Link
US (1) US20090208939A1 (no)
EP (1) EP1848818A1 (no)
JP (1) JP2008537474A (no)
KR (1) KR20080016789A (no)
CN (1) CN101124340A (no)
AU (1) AU2005327929A1 (no)
BR (1) BRPI0520012A2 (no)
CA (1) CA2596932A1 (no)
IL (1) IL184920A0 (no)
MX (1) MX2007009562A (no)
NO (1) NO20074762L (no)
WO (1) WO2006091254A1 (no)
ZA (1) ZA200707752B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9222938B2 (en) * 2001-12-04 2015-12-29 Michael Tainsky Neoepitope detection of disease using protein arrays
WO2008123901A2 (en) * 2007-02-06 2008-10-16 Genizon Biosciences Genemap of the human genes associated with endometriosis
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
WO2009140126A1 (en) * 2008-05-14 2009-11-19 Juneau Biosciences, Llc Method of administering a therapeutic
WO2010124101A2 (en) 2009-04-22 2010-10-28 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
JP5503942B2 (ja) 2009-10-30 2014-05-28 シスメックス株式会社 疾患の罹患の判定方法
EP2348129A1 (en) * 2010-01-21 2011-07-27 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
KR101333207B1 (ko) * 2011-07-13 2013-11-26 부산대학교 산학협력단 자궁내막증과 연관된 유전자 마커 및 이의 용도
EP2773779B1 (en) 2011-11-04 2020-10-14 Population Bio, Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions
DK2812452T3 (da) 2012-02-09 2020-06-29 Population Bio Inc Fremgangsmåder og sammensætninger til screening og behandling af udviklingsforstyrrelser
KR101445560B1 (ko) 2012-05-10 2014-09-29 한국수력원자력 주식회사 저준위 전리방사선에 민감한 유전자 검출 방법 및 상기 방법으로 검출된 유전자
EP2895621B1 (en) 2012-09-14 2020-10-21 Population Bio, Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
HK1218314A1 (zh) * 2013-06-28 2017-02-10 Acumen Research Laboratories Pte. Ltd. 脓毒症生物标志物及其应用
DK3511422T3 (da) * 2013-11-12 2023-02-06 Population Bio Inc Fremgangsmåder og sammensætninger til diagnosticering, prognose og behandling af endometriose
DE102014203235A1 (de) * 2014-02-24 2015-08-27 Mahle International Gmbh Klimagerät, insbesondere für ein Kraftfahrzeug und Verfahren zur Herstellung einer Komponente eines Klimagerätes
RU2558854C1 (ru) * 2014-06-23 2015-08-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Способ прогнозирования риска развития эндометриоза
JP2016077234A (ja) * 2014-10-17 2016-05-16 国立大学法人鳥取大学 子宮内膜症の早期診断のための診断キット、診断マーカー及び検出方法
CN107326065B (zh) * 2016-04-29 2022-07-29 博尔诚（北京）科技有限公司 一种基因标识物的筛选方法及其应用
CN107858415B (zh) * 2016-09-19 2021-05-28 深圳华大生命科学研究院 用于子宫腺肌症检测的生物标志物组合及其应用
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
US10729693B2 (en) * 2018-03-02 2020-08-04 Ponce Medical School Foundation, Inc. Compositions and methods for the treatment of endometriosis
CN108456723A (zh) * 2018-03-21 2018-08-28 福州福瑞医学检验实验室有限公司 一种子宫内膜异位症风险预测的基因检测引物和试剂盒
KR102897619B1 (ko) * 2018-04-20 2025-12-09 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 자궁내막증을 치료하기 위한 조성물 및 방법
US11906529B1 (en) * 2018-04-27 2024-02-20 Marshall University Research Corporation Methods for treatment and diagnosis of endometriosis
EP4177356B1 (en) 2018-08-08 2024-05-08 PML Screening, LLC Methods for assessing risk of developing a viral disease using a genetic test
WO2024263816A2 (en) * 2023-06-21 2024-12-26 Cristcot Llc Development and validation of the hemorrhoid disease symptom impact measure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60321356D1 (de) * 2002-08-30 2008-07-10 Oncotherapy Science Inc Verfahren zur diagnostik von eierstock endometriose

Also Published As

Publication number Publication date
WO2006091254A1 (en) 2006-08-31
CA2596932A1 (en) 2006-08-31
ZA200707752B (en) 2010-05-26
CN101124340A (zh) 2008-02-13
US20090208939A1 (en) 2009-08-20
EP1848818A1 (en) 2007-10-31
KR20080016789A (ko) 2008-02-22
MX2007009562A (es) 2008-03-11
BRPI0520012A2 (pt) 2009-04-14
IL184920A0 (en) 2007-12-03
JP2008537474A (ja) 2008-09-18
AU2005327929A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
NO20074762L (no) Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter
NO20091572L (no) Biosensorsystem som har forsterket stabilitet og hematokrittytelse
Krige et al. Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis
ES2640532T3 (es) Métodos para la detección de papilomavirus humano y proporcionar un pronóstico para el carcinoma de células escamosas de cabeza y cuello
BRPI0509193A (pt) métodos e composições para a detecção de doença cervical
KR20160045547A (ko) 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
MX2007009427A (es) Metodo diagnostico de la esteatosis hepatica utilizando marcadores bioquimicos.
WO2008041953A3 (en) Dengue diagnosis and treatment
EP2287618A3 (en) Method for diagnosing neuro-degenerative disease
KR102604430B1 (ko) 각막 내피 세포의 기능 부전 진단용 바이오마커
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
US10330682B2 (en) Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using same
WO2007103211A3 (en) Methods to identify fat and lean animals using class predictors
MX2008011665A (es) Diagnóstico y pronóstico de los estados patológicos asociados a la dipeptidil-peptidasa.
Wan et al. Plasma long noncoding RNA IL‐7R as a prognostic biomarker for clinical outcomes in patients with acute respiratory distress syndrome
Talla et al. Immuno‐oncology gene expression profiling of formalin‐fixed and paraffin‐embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing
Haq et al. Identification of specific biomarkers for anaplastic thyroid carcinoma through spatial transcriptomic and immunohistochemical profiling
Paziewska et al. Mass spectrometry‐based comprehensive analysis of pancreatic cyst fluids
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
Ahmed et al. Proteomics-based mapping of bronchopulmonary dysplasia-associated changes in noninvasively accessible oral secretions
KR101594980B1 (ko) 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
Paulo et al. Mass spectrometry-based (GeLC-MS/MS) comparative proteomic analysis of endoscopically (ePFT) collected pancreatic and gastroduodenal fluids
Chen et al. SELDI protein chip technology for the detection of serum biomarkers for liver disease
WO2005118403A3 (en) Methods for detecting gene expression in peripheral blood cells and uses thereof
WO2008062314A3 (en) Circulating ve-cadherin as a predictive marker of sensitivity or resistance to anti-tumoral treatment, and improved method for the detection of soluble proteins.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application